Koers SciVision Biotech Inc.
Aandelen
1786
TW0001786002
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
108 TWD | -1,37% | +3,85% | +39,18% |
Omzet 2022 | 557 mln. 17,11 mln. 15,98 mln. | Omzet 2023 | 713 mln. 21,89 mln. 20,44 mln. | Marktkapitalisatie | 5,25 mld. 161 mln. 151 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 142 mln. 4,36 mln. 4,07 mln. | Nettowinst (verlies) 2023 | 178 mln. 5,46 mln. 5,1 mln. | EV/omzet 2022 | 6,07 x |
Nettoliquiditeiten 2022 | 206 mln. 6,32 mln. 5,9 mln. | Nettoliquiditeiten 2023 | 397 mln. 12,19 mln. 11,38 mln. | EV/omzet 2023 | 6,81 x |
K/w-verhouding 2022 |
28,2
x | K/w-verhouding 2023 |
32,2
x | Werknemers | - |
Dividendrendement 2022 |
3,69% | Dividendrendement 2023 |
3,22% | Vrij verhandelbaar | 65,19% |
1 dag | -1,37% | ||
1 week | +3,85% | ||
Lopende maand | +10,88% | ||
1 maand | +13,68% | ||
3 maanden | +43,81% | ||
6 maanden | +40,81% | ||
Lopend jaar | +39,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kai Cheng Han
CEO | Chief Executive Officer | - | 14-06-02 |
Chun Nan Lin
DFI | Director of Finance/CFO | - | - |
Ju Ling Kuo
DFI | Director of Finance/CFO | - | 28-07-03 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ta Wen Sun
BRD | Director/Board Member | - | - |
Director/Board Member | - | 09-06-11 | |
Kai Cheng Han
CEO | Chief Executive Officer | - | 14-06-02 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 108 | -1,37% | 380 277 |
25-04-24 | 109,5 | +1,39% | 705 992 |
24-04-24 | 108 | +0,93% | 570 969 |
23-04-24 | 107 | +3,88% | 832 876 |
22-04-24 | 103 | -0,96% | 445 563 |
slotkoers Taiwan S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+39,18% | 224 mln. | |
+12,07% | 128 mld. | |
-9,04% | 10,65 mld. | |
+0,91% | 8,82 mld. | |
+16,72% | 7,19 mld. | |
+25,15% | 4,99 mld. | |
+7,17% | 3,4 mld. | |
-1,36% | 3,03 mld. | |
-8,73% | 2,14 mld. | |
-10,15% | 2 mld. |